Skip to main content
Equibles

BARCLAYS PLC

Position in LXEO — Lexeo Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to LXEO Full portfolio

Position in LXEO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$75,675
+$5,849 QoQ
Shares Held
16,257
+33.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 141 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LXEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. LXEO ranks #260 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in LXEO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $75,675 16,257
2026-03-31 $69,826 12,165
2025-12-31 $1,874,327 188,754
2025-09-30 $740,884 111,579
2025-06-30 $466,890 116,142
2025-03-31 $161,934 46,667
2024-12-31 $362,959 55,161
2024-09-30 $453,898 50,210
2024-06-30 $307,214 19,153
2024-03-31 $359,526 22,929
2023-12-31 $208,238 15,517